CN114634948A - Bioreactor for instantaneously expressing foreign protein by using medlar as tobacco mosaic virus - Google Patents
Bioreactor for instantaneously expressing foreign protein by using medlar as tobacco mosaic virus Download PDFInfo
- Publication number
- CN114634948A CN114634948A CN202011477593.2A CN202011477593A CN114634948A CN 114634948 A CN114634948 A CN 114634948A CN 202011477593 A CN202011477593 A CN 202011477593A CN 114634948 A CN114634948 A CN 114634948A
- Authority
- CN
- China
- Prior art keywords
- protein
- agrobacterium
- lycium
- plant
- medlar
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 108090000623 proteins and genes Proteins 0.000 title claims abstract description 71
- 102000004169 proteins and genes Human genes 0.000 title claims abstract description 64
- 241000723873 Tobacco mosaic virus Species 0.000 title claims abstract description 26
- 235000017784 Mespilus germanica Nutrition 0.000 title claims abstract description 20
- 235000000560 Mimusops elengi Nutrition 0.000 title claims abstract description 20
- 235000007837 Vangueria infausta Nutrition 0.000 title claims abstract description 20
- 244000182216 Mimusops elengi Species 0.000 title claims abstract 7
- 241000196324 Embryophyta Species 0.000 claims abstract description 40
- 241000589158 Agrobacterium Species 0.000 claims abstract description 39
- 229960005486 vaccine Drugs 0.000 claims abstract description 24
- 238000004519 manufacturing process Methods 0.000 claims abstract description 17
- 230000014509 gene expression Effects 0.000 claims abstract description 15
- 239000013604 expression vector Substances 0.000 claims abstract description 11
- 235000016709 nutrition Nutrition 0.000 claims abstract description 11
- 238000002360 preparation method Methods 0.000 claims abstract description 10
- 244000241838 Lycium barbarum Species 0.000 claims description 38
- 235000015459 Lycium barbarum Nutrition 0.000 claims description 38
- 238000000034 method Methods 0.000 claims description 19
- 239000013598 vector Substances 0.000 claims description 14
- 241001106041 Lycium Species 0.000 claims description 11
- 241000169546 Lycium ruthenicum Species 0.000 claims description 3
- 241000617254 Lycium yunnanense Species 0.000 claims description 3
- 241000617255 Lycium truncatum Species 0.000 claims 1
- 108700008625 Reporter Genes Proteins 0.000 abstract description 8
- 239000013603 viral vector Substances 0.000 abstract description 6
- 229940126578 oral vaccine Drugs 0.000 abstract description 5
- 229920001184 polypeptide Polymers 0.000 abstract description 4
- 108090000765 processed proteins & peptides Proteins 0.000 abstract description 4
- 102000004196 processed proteins & peptides Human genes 0.000 abstract description 4
- 241000589155 Agrobacterium tumefaciens Species 0.000 abstract description 3
- 230000036541 health Effects 0.000 abstract description 3
- 235000015097 nutrients Nutrition 0.000 abstract description 3
- 235000013376 functional food Nutrition 0.000 abstract description 2
- 230000036039 immunity Effects 0.000 abstract description 2
- 230000035764 nutrition Effects 0.000 abstract description 2
- 239000013589 supplement Substances 0.000 abstract description 2
- 239000005090 green fluorescent protein Substances 0.000 description 21
- 240000002624 Mespilus germanica Species 0.000 description 13
- 238000002347 injection Methods 0.000 description 11
- 239000007924 injection Substances 0.000 description 11
- 230000010474 transient expression Effects 0.000 description 11
- 241000700605 Viruses Species 0.000 description 10
- 244000241872 Lycium chinense Species 0.000 description 9
- 235000015468 Lycium chinense Nutrition 0.000 description 8
- 239000000463 material Substances 0.000 description 8
- 238000002474 experimental method Methods 0.000 description 5
- 239000013642 negative control Substances 0.000 description 5
- 239000000047 product Substances 0.000 description 5
- 238000001262 western blot Methods 0.000 description 5
- JLIDBLDQVAYHNE-YKALOCIXSA-N (+)-Abscisic acid Chemical compound OC(=O)/C=C(/C)\C=C\[C@@]1(O)C(C)=CC(=O)CC1(C)C JLIDBLDQVAYHNE-YKALOCIXSA-N 0.000 description 4
- 241000282414 Homo sapiens Species 0.000 description 4
- 241000208125 Nicotiana Species 0.000 description 4
- 235000002637 Nicotiana tabacum Nutrition 0.000 description 4
- 229940124158 Protease/peptidase inhibitor Drugs 0.000 description 4
- 238000004458 analytical method Methods 0.000 description 4
- 239000000872 buffer Substances 0.000 description 4
- 238000001514 detection method Methods 0.000 description 4
- 238000001917 fluorescence detection Methods 0.000 description 4
- 239000007788 liquid Substances 0.000 description 4
- 239000000137 peptide hydrolase inhibitor Substances 0.000 description 4
- 230000003612 virological effect Effects 0.000 description 4
- 241000894006 Bacteria Species 0.000 description 3
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 3
- 240000008415 Lactuca sativa Species 0.000 description 3
- 235000003228 Lactuca sativa Nutrition 0.000 description 3
- 241000208292 Solanaceae Species 0.000 description 3
- 238000012258 culturing Methods 0.000 description 3
- 238000005516 engineering process Methods 0.000 description 3
- 239000012634 fragment Substances 0.000 description 3
- 239000002773 nucleotide Substances 0.000 description 3
- 125000003729 nucleotide group Chemical group 0.000 description 3
- 235000013311 vegetables Nutrition 0.000 description 3
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- 244000025254 Cannabis sativa Species 0.000 description 2
- 239000006137 Luria-Bertani broth Substances 0.000 description 2
- 241000139369 Lycium cylindricum Species 0.000 description 2
- 240000007594 Oryza sativa Species 0.000 description 2
- 235000007164 Oryza sativa Nutrition 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 244000061458 Solanum melongena Species 0.000 description 2
- 235000002597 Solanum melongena Nutrition 0.000 description 2
- FCRACOPGPMPSHN-UHFFFAOYSA-N desoxyabscisic acid Natural products OC(=O)C=C(C)C=CC1C(C)=CC(=O)CC1(C)C FCRACOPGPMPSHN-UHFFFAOYSA-N 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 235000018927 edible plant Nutrition 0.000 description 2
- 239000011536 extraction buffer Substances 0.000 description 2
- 238000005286 illumination Methods 0.000 description 2
- 229930027917 kanamycin Natural products 0.000 description 2
- 229960000318 kanamycin Drugs 0.000 description 2
- SBUJHOSQTJFQJX-NOAMYHISSA-N kanamycin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CN)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](N)[C@H](O)[C@@H](CO)O2)O)[C@H](N)C[C@@H]1N SBUJHOSQTJFQJX-NOAMYHISSA-N 0.000 description 2
- 229930182823 kanamycin A Natural products 0.000 description 2
- 230000037039 plant physiology Effects 0.000 description 2
- 238000012545 processing Methods 0.000 description 2
- 238000000751 protein extraction Methods 0.000 description 2
- 235000009566 rice Nutrition 0.000 description 2
- 238000012216 screening Methods 0.000 description 2
- 230000019491 signal transduction Effects 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- 229940031626 subunit vaccine Drugs 0.000 description 2
- 239000006228 supernatant Substances 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- 244000144730 Amygdalus persica Species 0.000 description 1
- 241001632409 Aralia elata Species 0.000 description 1
- 235000015888 Aralia elata Nutrition 0.000 description 1
- 208000025721 COVID-19 Diseases 0.000 description 1
- 235000002566 Capsicum Nutrition 0.000 description 1
- 240000008574 Capsicum frutescens Species 0.000 description 1
- 244000271246 Cedrela sinensis Species 0.000 description 1
- 235000011783 Cedrela sinensis Nutrition 0.000 description 1
- 240000006122 Chenopodium album Species 0.000 description 1
- 235000009344 Chenopodium album Nutrition 0.000 description 1
- 238000011537 Coomassie blue staining Methods 0.000 description 1
- 241000723655 Cowpea mosaic virus Species 0.000 description 1
- 241000450599 DNA viruses Species 0.000 description 1
- 241000223218 Fusarium Species 0.000 description 1
- 241000287828 Gallus gallus Species 0.000 description 1
- 101710096409 Germin-like protein Proteins 0.000 description 1
- 239000005980 Gibberellic acid Substances 0.000 description 1
- 108010043121 Green Fluorescent Proteins Proteins 0.000 description 1
- 102000004144 Green Fluorescent Proteins Human genes 0.000 description 1
- 101000976075 Homo sapiens Insulin Proteins 0.000 description 1
- 102000006992 Interferon-alpha Human genes 0.000 description 1
- 108010047761 Interferon-alpha Proteins 0.000 description 1
- 244000017020 Ipomoea batatas Species 0.000 description 1
- 235000002678 Ipomoea batatas Nutrition 0.000 description 1
- 240000004658 Medicago sativa Species 0.000 description 1
- 235000017587 Medicago sativa ssp. sativa Nutrition 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 240000000249 Morus alba Species 0.000 description 1
- 235000008708 Morus alba Nutrition 0.000 description 1
- 241000207746 Nicotiana benthamiana Species 0.000 description 1
- 201000005702 Pertussis Diseases 0.000 description 1
- 244000046052 Phaseolus vulgaris Species 0.000 description 1
- 235000010627 Phaseolus vulgaris Nutrition 0.000 description 1
- 206010035664 Pneumonia Diseases 0.000 description 1
- 235000006040 Prunus persica var persica Nutrition 0.000 description 1
- 241000405911 Rehmannia glutinosa Species 0.000 description 1
- 244000061456 Solanum tuberosum Species 0.000 description 1
- 235000002595 Solanum tuberosum Nutrition 0.000 description 1
- 240000001949 Taraxacum officinale Species 0.000 description 1
- 235000005187 Taraxacum officinale ssp. officinale Nutrition 0.000 description 1
- 206010043376 Tetanus Diseases 0.000 description 1
- 239000007983 Tris buffer Substances 0.000 description 1
- 229920004890 Triton X-100 Polymers 0.000 description 1
- 239000013504 Triton X-100 Substances 0.000 description 1
- 235000010726 Vigna sinensis Nutrition 0.000 description 1
- 244000042314 Vigna unguiculata Species 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000006978 adaptation Effects 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 206010064097 avian influenza Diseases 0.000 description 1
- 229960000190 bacillus calmette–guérin vaccine Drugs 0.000 description 1
- 239000007853 buffer solution Substances 0.000 description 1
- 239000001390 capsicum minimum Substances 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 238000011109 contamination Methods 0.000 description 1
- 229940028617 conventional vaccine Drugs 0.000 description 1
- 238000005520 cutting process Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000004069 differentiation Effects 0.000 description 1
- 206010013023 diphtheria Diseases 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 210000002257 embryonic structure Anatomy 0.000 description 1
- 238000011049 filling Methods 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 108020001507 fusion proteins Proteins 0.000 description 1
- 102000037865 fusion proteins Human genes 0.000 description 1
- IXORZMNAPKEEDV-UHFFFAOYSA-N gibberellic acid GA3 Natural products OC(=O)C1C2(C3)CC(=C)C3(O)CCC2C2(C=CC3O)C1C3(C)C(=O)O2 IXORZMNAPKEEDV-UHFFFAOYSA-N 0.000 description 1
- IXORZMNAPKEEDV-OBDJNFEBSA-N gibberellin A3 Chemical compound C([C@@]1(O)C(=C)C[C@@]2(C1)[C@H]1C(O)=O)C[C@H]2[C@]2(C=C[C@@H]3O)[C@H]1[C@]3(C)C(=O)O2 IXORZMNAPKEEDV-OBDJNFEBSA-N 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- SPSXSWRZQFPVTJ-ZQQKUFEYSA-N hepatitis b vaccine Chemical compound C([C@H](NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CO)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC=1C2=CC=CC=C2NC=1)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](N)CCSC)C(=O)N[C@@H](CC1N=CN=C1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C(C)C)C(=O)OC(=O)CNC(=O)CNC(=O)[C@H](C)NC(=O)[C@H]1N(CCC1)C(=O)[C@H](CC=1C=CC=CC=1)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@@H](N)CCCNC(N)=N)C1=CC=CC=C1 SPSXSWRZQFPVTJ-ZQQKUFEYSA-N 0.000 description 1
- 229940124736 hepatitis-B vaccine Drugs 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 206010022000 influenza Diseases 0.000 description 1
- 229960003971 influenza vaccine Drugs 0.000 description 1
- PBGKTOXHQIOBKM-FHFVDXKLSA-N insulin (human) Chemical compound C([C@@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@H]1CSSC[C@H]2C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@H](C(N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC=3C=CC(O)=CC=3)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC=3C=CC(O)=CC=3)C(=O)N[C@@H](CSSC[C@H](NC(=O)[C@H](C(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC=3C=CC(O)=CC=3)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](C(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC=3NC=NC=3)NC(=O)[C@H](CO)NC(=O)CNC1=O)C(=O)NCC(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)NCC(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(O)=O)C(=O)N[C@@H](CC(N)=O)C(O)=O)=O)CSSC[C@@H](C(N2)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](C(C)C)NC(=O)[C@@H](NC(=O)CN)[C@@H](C)CC)[C@@H](C)CC)[C@@H](C)O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@@H](N)CC=1C=CC=CC=1)C(C)C)C1=CN=CN1 PBGKTOXHQIOBKM-FHFVDXKLSA-N 0.000 description 1
- 238000011031 large-scale manufacturing process Methods 0.000 description 1
- 244000144972 livestock Species 0.000 description 1
- 238000011068 loading method Methods 0.000 description 1
- TWRXJAOTZQYOKJ-UHFFFAOYSA-L magnesium chloride Substances [Mg+2].[Cl-].[Cl-] TWRXJAOTZQYOKJ-UHFFFAOYSA-L 0.000 description 1
- 229910001629 magnesium chloride Inorganic materials 0.000 description 1
- 239000002398 materia medica Substances 0.000 description 1
- 229940041323 measles vaccine Drugs 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 239000004570 mortar (masonry) Substances 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 239000008188 pellet Substances 0.000 description 1
- 239000006187 pill Substances 0.000 description 1
- 239000013612 plasmid Substances 0.000 description 1
- 229960001539 poliomyelitis vaccine Drugs 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 238000002331 protein detection Methods 0.000 description 1
- 239000012474 protein marker Substances 0.000 description 1
- 238000001742 protein purification Methods 0.000 description 1
- 229940023143 protein vaccine Drugs 0.000 description 1
- 238000012113 quantitative test Methods 0.000 description 1
- 230000006798 recombination Effects 0.000 description 1
- 238000005215 recombination Methods 0.000 description 1
- 238000004064 recycling Methods 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- JQXXHWHPUNPDRT-WLSIYKJHSA-N rifampicin Chemical compound O([C@](C1=O)(C)O/C=C/[C@@H]([C@H]([C@@H](OC(C)=O)[C@H](C)[C@H](O)[C@H](C)[C@@H](O)[C@@H](C)\C=C\C=C(C)/C(=O)NC=2C(O)=C3C([O-])=C4C)C)OC)C4=C1C3=C(O)C=2\C=N\N1CC[NH+](C)CC1 JQXXHWHPUNPDRT-WLSIYKJHSA-N 0.000 description 1
- 229960001225 rifampicin Drugs 0.000 description 1
- 238000002791 soaking Methods 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 238000002415 sodium dodecyl sulfate polyacrylamide gel electrophoresis Methods 0.000 description 1
- 239000002689 soil Substances 0.000 description 1
- 238000009331 sowing Methods 0.000 description 1
- 230000009261 transgenic effect Effects 0.000 description 1
- 230000001052 transient effect Effects 0.000 description 1
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 1
- 239000010455 vermiculite Substances 0.000 description 1
- 229910052902 vermiculite Inorganic materials 0.000 description 1
- 235000019354 vermiculite Nutrition 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
- C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
- C12N15/8242—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits
- C12N15/8257—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits for the production of primary gene products, e.g. pharmaceutical products, interferon
- C12N15/8258—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits for the production of primary gene products, e.g. pharmaceutical products, interferon for the production of oral vaccines (antigens) or immunoglobulins
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
- C12N15/8201—Methods for introducing genetic material into plant cells, e.g. DNA, RNA, stable or transient incorporation, tissue culture methods adapted for transformation
- C12N15/8202—Methods for introducing genetic material into plant cells, e.g. DNA, RNA, stable or transient incorporation, tissue culture methods adapted for transformation by biological means, e.g. cell mediated or natural vector
- C12N15/8205—Agrobacterium mediated transformation
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
- C12N15/8201—Methods for introducing genetic material into plant cells, e.g. DNA, RNA, stable or transient incorporation, tissue culture methods adapted for transformation
- C12N15/8209—Selection, visualisation of transformants, reporter constructs, e.g. antibiotic resistance markers
- C12N15/821—Non-antibiotic resistance markers, e.g. morphogenetic, metabolic markers
- C12N15/8212—Colour markers, e.g. beta-glucoronidase [GUS], green fluorescent protein [GFP], carotenoid
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
- C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
- C12N15/8242—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits
- C12N15/8257—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits for the production of primary gene products, e.g. pharmaceutical products, interferon
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Chemical & Material Sciences (AREA)
- Biotechnology (AREA)
- Molecular Biology (AREA)
- Wood Science & Technology (AREA)
- Organic Chemistry (AREA)
- General Engineering & Computer Science (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Cell Biology (AREA)
- Microbiology (AREA)
- Plant Pathology (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Physics & Mathematics (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Immunology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Peptides Or Proteins (AREA)
Abstract
The invention discloses a bioreactor for instantaneously expressing foreign protein by using medlar as tobacco mosaic virus. The invention discloses a recombinant tobacco mosaic virus expression vector containing a coding gene of exogenous protein is introduced into agrobacterium to obtain recombinant agrobacterium; the recombinant agrobacterium obtained is used for infecting the medlar, and the exogenous protein can be expressed in the medlar. The GFP exogenous reporter gene is successfully expressed in the medlar leaves which are rich in nutrition and have medicinal value through a TMV viral vector and an agrobacterium tumefaciens instant expression system. The invention can create new preparation (such as oral preparation) of exogenous nutrient protein, medical polypeptide and protein (such as vaccine), can promote people to improve the immunity of the public and the health of the people by eating the functional food 'daily oral vaccine' containing vaccine components, is an important supplement for the plant production vaccine industry, and has important social significance and application prospect.
Description
Technical Field
The invention relates to the field of biotechnology, and discloses a bioreactor for instantaneously expressing foreign protein by using medlar as tobacco mosaic virus.
Background
The vaccine is not only used for preventing important diseases (such as BCG vaccine, poliomyelitis vaccine, diphtheria-pertussis-tetanus combined vaccine, measles vaccine, hepatitis B vaccine and the like) and annual epidemic diseases (such as human or livestock flu) which are abused by human beings, but also is an effective measure for dealing with sudden pestilence (such as novel coronary pneumonia COVID-19), and has important significance in human health and improvement of life quality. The use of large quantities of pathogens of animal origin (e.g. chicken embryos) in the production of conventional vaccines (e.g. influenza vaccines) presents a potential risk of contamination and a sudden large demand that is difficult to meet due to the time frame of production. In recent years, scientists have used plant virus vectors in combination with agrobacterium transient expression (differentiation) technology to produce medical protein and subunit vaccines, and the system has the advantages of high foreign protein expression, short time, low cost, safety, large-scale production and the like, so that the system is currently applied to European and American medicine commercial production, such as the company of plant biotechnology, Dow AgroScience, and the company of Protalix, Biolex, SemBosys, and the company of medical, and the company of Dow AgroScience, respectively and successfully develop alpha-galactosidiase A, human interferon alpha, human insulin, H5N1 influenza subunit vaccines. The large-scale application of Magnifection technology promotes the vaccine industry to enter a new era of producing vaccines by plants! At present, China still belongs to the stage of overtaking and filling up the blank in the field.
Plant viral vectors involved in the production of vaccines by plants include various expression vectors such as Tobacco viral viruses (TMV), Potato Viral X (PVX), Alfalfa viral viruses (AMV), Cowpea viral viruses (CPMV), and DNA viruses Bean yellow dewar viruses (BeYDV), and only TMV vectors are currently successfully used in commercial production. Plant materials used for producing vaccines by using TMV viral vectors, namely 'vaccine processing workshops', are Nicotiana benthamiana (Nb). Due to the inedibility of tobacco, foreign protein needs to be purified from tobacco in the process flow of producing vaccine by plants, and the problems of processing cost and protein yield rate caused by expensive price/recycling and the like of the used protein purification chromatographic column are limiting factors in production. Therefore, it is possible to find an edible plant to bring new breakthrough to oral vaccine production, and it has been reported that the application of vegetable plants such as lettuce (Lactuca sativa), eggplant (Solanum melongena) and the like in the agrobacterium transient expression system is attempted, but the plant propagation production process is limited to the laboratory research stage due to low protein expression level and the like.
Lycium barbarum (Lycium barbarum) is a multi-branched shrub plant of the genus Lycium (Lycium) of the family Solanaceae (Solanaceae). The whole body of medlar is treasure, and the Ming Li Shizhen's book of compendium of materia Medica: spring collected folium Lycii, named Tianjing grass; summer flower, named Changsheng grass; named as fructus Lycii; collected root in winter, named cortex lycii radicis. Lycium chinense seeds are well known as health-preserving food materials and high-immunity medicinal materials, tender leaves of Lycium chinense can be used as vegetables and vegetables, the nutritional value of Lycium chinense is increasingly valued by people, and related varieties of Lycium chinense are cultivated and applied.
Disclosure of Invention
The technical problem to be solved by the invention is how to express the medical or edible exogenous protein in edible plants in a transient and high-efficiency manner by a non-transgenic technology.
In order to solve the above technical problems, the present invention provides a method for expressing a foreign protein in a plant, wherein the plant is lycium barbarum, the method comprising: introducing a recombinant tobacco mosaic virus expression vector containing a coding gene of exogenous protein into agrobacterium to obtain recombinant agrobacterium; and infecting the medlar by using the recombinant agrobacterium to realize the expression of the foreign protein in the plant.
In the above method, the recombinant tobacco mosaic virus expression vector may be obtained by inserting a gene encoding the foreign protein into a tobacco mosaic virus vector.
In the above method, the tobacco mosaic virus vector may be p 35S-30B.
In the above method, the agrobacterium may be agrobacterium strain GV 3101.
In the above method, the Lycium barbarum can be a Lycium plant.
The Lycium plant may be Lycium barbarum L, Lycium barbarum Mill, Lycium ruthenicum Murr, Lycium barbarum Pojark, Lycium barbarum Y.C.Wang, Lycium cylindricum Kuang, or Lycium yunnanense Kuang.
In one embodiment of the invention, the Lycium barbarum (Lycium barbarum L) is Lycium barbarum No. 9.
The invention also provides a kit comprising the tobacco mosaic virus vector and the agrobacterium.
The kit may further comprise said wolfberries.
The kit can be composed of the tobacco mosaic virus vector and the agrobacterium, and can also be composed of the tobacco mosaic virus vector, the agrobacterium and the medlar.
The kit can be used for expressing a foreign protein in a plant, or preparing a product for expressing a foreign protein in a plant, or producing a medical protein, vaccine or nutritional protein, or preparing a product for producing a medical protein, vaccine or nutritional protein.
Any of the following uses of the kit also fall within the scope of the invention:
x1, expressing a foreign protein in a plant;
x2, preparation of a product for expressing a foreign protein in a plant;
x3, production of a protein for medical use, vaccine or nutritional protein;
x4, preparation of products for the production of proteins for medical use, vaccines or nutritional proteins.
The vaccine may be an oral vaccine.
In the above application, the plant may be fructus Lycii. The Lycium barbarum can be a Lycium plant.
The Lycium plant may be Lycium barbarum L, Lycium barbarum Mill, Lycium ruthenicum Murr, Lycium barbarum Pojark, Lycium barbarum Y.C.Wang, Lycium cylindricum Kuang, or Lycium yunnanense Kuang.
In one embodiment of the invention, the Lycium barbarum (Lycium barbarum L) is Lycium barbarum No. 9.
In one embodiment of the present invention, the exogenous protein is green fluorescent protein.
The GFP exogenous reporter gene is successfully expressed in the medlar leaves which are rich in nutrition and have medicinal value through a TMV viral vector and an agrobacterium tumefaciens instant expression system. Because the plants of the lycium genus and the tobacco which is widely applied to the plants for producing the vaccines belong to the solanaceae family, the lycium macrocarpum has nutritional and medicinal values, is suitable for asexual propagation such as cuttage, pile cutting and the like, keeps the stable and consistent genotype, has low cost, can be produced in a large scale and the like. The present invention provides safe and edible oral preparation of medical polypeptide and protein, such as vaccine, without high purity and difficult preparation steps. The invention can create new preparation (such as oral preparation) of exogenous nutrient protein, medical polypeptide and protein (such as vaccine), can promote people to improve the immunity of the public and the health of the people by eating the functional food 'daily oral vaccine' containing vaccine components, is an important supplement for the plant production vaccine industry, and has important social significance and application prospect.
Drawings
FIG. 1 fluorescent detection of GFP reporter gene expression on Lycii folium by Agrobacterium transient expression system.
30, 35 and 80d seedlings of the medlar seeds are respectively injected with agrobacterium GV3101 containing TMV viral vector (pAT-His-eGFP) of exogenous reporter gene and plant expression vector (130-GFP), wherein the injection of MMA buffer solution is Mock negative control. Fluorescence observation was performed when the culture was continued for 3,5,7 and 10dpa (days post agroinfiltration), respectively, after the Agrobacterium injection. In the figure, p130-GFP represents 130-GFP.
FIG. 2 detection of His-eGFP expressing proteins in Lycii folium.
And extracting total soluble protein of the medlar leaf blade injected with pAT-His-eGFP agrobacterium, and carrying out His-eGFP protein expression detection. (A) Coomassie blue staining for His-eGFP expression, M: a protein Marker; MMA: a Mock negative control; #1, #2 and #3 represent different lycium barbarum plants; the sample amounts in the lanes were 4.5mg total soluble protein from fresh weight leaves. The red arrow indicates His-eGFP.
(B) Western blot analysis was performed using His-tag antibody. The loading of lanes was 2.7mg fresh weight of total soluble protein.
Detailed Description
The present invention is described in further detail below with reference to specific embodiments, which are given for the purpose of illustration only and are not intended to limit the scope of the invention. The examples provided below serve as a guide for further modifications by a person skilled in the art and do not constitute a limitation of the invention in any way.
The experimental procedures in the following examples, unless otherwise specified, were carried out in a conventional manner according to the techniques or conditions described in the literature in this field or according to the product instructions. Materials, reagents, instruments and the like used in the following examples are commercially available unless otherwise specified. The quantitative tests in the following examples, all set up three replicates and the results averaged. In the following examples, unless otherwise specified, the 1 st position of each nucleotide sequence in the sequence listing is the 5 'terminal nucleotide of the corresponding DNA/RNA, and the last position is the 3' terminal nucleotide of the corresponding DNA/RNA.
Examples 1,
1. Materials and methods
1.1 materials:
lycium barbarum seed (Lycium barbarum) (ningxia Lycium barbarum No. 9); agrobacterium strain GV 3101.
1.2 method:
(1) constructing a vector and a recombinant bacterium:
Agrobacterium-TMV virus expression vector p35S-30B (ref. Hongge Jia, Yongqi Page, Rongxiang Fang, agriculture infection as a simple way to a background a. tobaco biological virus-based expression vector, Acta Botanica Sinica 2003,45: 770-773; preserved in the institute of microbiology of the national institute of plant genomics, publicly available from the institute of microbiology of the national institute of sciences), was digested with PacI and KpnI and inserted into a His-eGFP reporter gene fragment with a tag in combination with a recombination system, and the resulting recombinant plasmid was named pAT-His-eGFP. pAT-His-eGFP is a recombinant vector obtained by replacing the DNA fragment between the PacI and KpnI recognition sequences of p35S-30B with the DNA fragment shown in sequence 1 in the sequence table.
Wherein, the 76 th to 807 th sites of the sequence 1 are eGFP gene sequences.
In addition, the reference plant expression vector 130-GFP [ i.e., P ] was also used in the experiments35SeGFP, reference Wang H, Zhang Y, Xiao N, Zhang G, Wang F, Chen X, and Fang R (2020) Rice Transformer-LIKE PROTEIN 2-1Functions in selected university under the Control of Abscisic Acid and Gibberellic Acid signalling pathways plant Physiology 183:1157 1170, publicly available from the national academy of sciences microbiology]。
Introducing the pAT-His-eGFP into an agrobacterium strain GV3101 to obtain a recombinant strain GV 3101/pAT-His-eGFP; the reference plant expression vector 130-GFP is introduced into the agrobacterium strain GV3101 to obtain the recombinant strain GV 3101/130-GFP.
(2) Culturing medlar seedlings:
soaking the medlar seeds in water for one day, and then directly sowing the seeds in vermiculite: in a culture medium of nutrient soil (1:1), transplanting seedlings after culturing for 10 days at 22 ℃ in a plant greenhouse (illumination for 16 h/darkness for 8h), and respectively carrying out agrobacterium tumefaciens transient expression experiments when the seedlings are continuously cultured in the plant greenhouse to 30d, 35d and 80 d.
(3) And (3) agrobacterium injection:
reference is made to the published articles and slightly modified [ Wang H, Zhang Y, Xiao N, Zhang G, Wang F, Chen X, and Fan R (2020) Rice GERMIN-LIKE PROTEIN 2-1Functions in selected university under the Control of Abscisic Acid and Gibberella Acid signalling pathway plant Physiology 183:1157 Ash 1170 ]. The method comprises the following specific steps:
inoculating the recombinant strain GV3101/pAT-His-eGFP or the recombinant strain GV3101/130-GFP to the strain containingAfter shaking culture at 220rpm/28 ℃ overnight in LB broth containing 50. mu.g/ml Kanamycin (Kanamycin, Kan) and 50. mu.g/ml Rifampicin (Rifamicin, Rif) antibiotics, the cells were diluted at 1/100 and transferred to LB broth (containing 50. mu.g/ml Kan,10mM MES, 20. mu.M AS), and the culture was continued until OD600 became 1.0, and then centrifuged at 12,000rpm for 30sec, the supernatant was discarded, and the pellet was collected. Using MMA buffer (solvent is water, solute and its concentration are respectively 10mM MgCl210mM MES and 100 μ M AS) and centrifuged again, and the cells were resuspended with MMA buffer to OD600 ═ 0.8. Standing at room temperature for 2-3 h. Finally, recombinant agrobacterium containing pAT-His-eGFP or 130-GFP is injected into the back of each Chinese wolfberry leaf by a 1ml syringe without a needle, 3 Chinese wolfberry plants are injected into each bacterium, and 9 leaves are counted. And (5) continuously culturing for 3-10 days under illumination, and then analyzing and detecting the exogenous gene. The Mock negative control was the MMA buffer injected to suspend the bacteria.
(4) Detection and analysis of exogenous reporter gene:
1) eGFP fluorescence detection: the whole plant after injection is put under dark condition and ultraviolet lamp (c)UVP Upland CA91786, u.s.a.) and observing eGFP protein expression. Normal non-expressing control leaves showed red color, while eGFP highly expressed injection leaves showed green fluorescence.
2) Western blot protein detection of eGFP: the leaves of Lycium barbarum injected with recombinant Agrobacterium containing pAT-His-eGFP or 130-GFP were harvested with liquid nitrogen and frozen and stored at-80 ℃ until use. The sample was ground well to a powder in a pre-cooled mortar and 2ml of protein extraction buffer [ solvent ddH ] was added according to a fresh weight of 1g2O, solute and its concentration were 50mM Tris (pH 7.5),150mM NaCl, 10% glycerol, 0.5% Triton X-100 and complete protease inhibitor cocktail, respectively. Wherein the working concentration of the Protease Inhibitor complete Protease Inhibitor Cocktail (Roche, Mini Protease Inhibitor Cocktail, Cat: 11836153001) is 1 pill/10 ml protein extraction buffer]After rotating at 4 ℃ for 30min, centrifuging at 4 ℃ for 15min at 12,000rpm twice, taking the supernatant and respectively performing protein SDS-PAGE and WeAnd (5) analyzing the sternblot.
The primary antibody used for Western blot was His-tag antibody (Sigma-Aldrich, cat # SAB2702220), and the secondary antibody was Anti-Mouse IgG (H + L), HRP Conjugate (Promega, cat #: w4021).
2. Results of the experiment
2.1 fluorescence detection of transient expression of GFP reporter genes in Lycium barbarum
Agrobacterium containing pAT-His-eGFP and p130-GFP was injected into 30, 35, and 80d extended leaves of Lycium barbarum seedlings at different growth stages by Agrobacterium injection transient expression system, and ultraviolet fluorescence detection analysis revealed that 3-10d of inoculated leaves of Lycium barbarum after injection all had strong blue-green fluorescence, whereas no fluorescence signal was observed in the negative control leaves injected with MMA buffer (FIG. 1), and this experiment result showed successful expression of active exogenous GFP protein in Lycium barbarum leaves by Agrobacterium transient expression system.
2.2 protein analysis of transient expression of GFP reporter Gene in Lycium barbarum
In order to confirm that the fluorescent signal on the injected leaves of lycium barbarum was a GFP foreign protein, Western blot assay was further performed with His-tagged antibody fused to eGFP (fig. 2), and the results showed that there was signal production with the expected size of His-GFP fusion protein (about 27kD) in the injected samples of lycium barbarum leaves, while the negative control leaves had no protein expression signal.
The invention proves that the Chinese wolfberry leaves are suitable for expressing active exogenous target protein through an agrobacterium transient expression system by combining fluorescence detection and Western blot protein analysis, establishes a practical novel method for producing exogenous polypeptide and protein by using Chinese wolfberry as a virus expression host, can be applied to the production of medical protein, vaccine, nutritional protein and the like, is particularly suitable for the development of oral vaccine, and has important application potential.
Comparative examples 1,
According to the method of example 1, lycium barbarum was replaced with mulberry, chenopodium album, dandelion, lettuce, rehmannia glutinosa, cedrela sinensis, peach tree, capsicum, sweet potato, aralia elata and lycium barbarum, respectively, and the injection of agrobacterium and the expression of eGFP are shown in table 1.
TABLE 1 plant screening for transient expression of GFP by Agrobacterium injection suitable for TMV viral vectors
Note: in table 1, in the column "easy to inject", X indicates that agrobacterium cannot be injected, i.e. the liquid in the injector is completely blocked and cannot be injected), V indicates that agrobacterium can be partially injected, i.e. a small amount of liquid is injected into the local tissue of the blade, VV indicates that agrobacterium is successfully injected, i.e. injection is easy, and liquid can be injected into the whole blade; in the "GFP fluorescence" column, X indicates that no green fluorescence signal is present and GFP cannot be expressed, VV indicates that an obvious fluorescence signal is present and eGFP is successfully expressed; NT means no test (not test).
The results show that, because the cell structures of different plant leaves are different, the affinity difference between the cells and the virus vector is large, and not all plants are suitable for a certain virus vector to express the foreign protein instantly, the medlar of the invention is used as a bioreactor for the tobacco mosaic virus to express the foreign protein instantly, and is a new material successfully obtained by screening various plants, such as various plant materials in the table 1, and only the medlar leaf has successful agrobacterium injection and high-efficiency expression.
The present invention has been described in detail above. It will be apparent to those skilled in the art that the invention can be practiced in a wide range of equivalent parameters, concentrations, and conditions without departing from the spirit and scope of the invention and without undue experimentation. While the invention has been described with reference to specific embodiments, it will be appreciated that the invention can be further modified. In general, this application is intended to cover any variations, uses, or adaptations of the invention following, in general, the principles of the invention and including such departures from the present disclosure as come within known or customary practice within the art to which the invention pertains. The use of some of the essential features is possible within the scope of the claims attached below.
<110> institute of microbiology of Chinese academy of sciences
<120> bioreactor for transient expression of foreign protein by using medlar as tobacco mosaic virus
<160> 1
<170> PatentIn version 3.5
<210> 1
<211> 1041
<212> DNA
<213> Artificial sequence (Artificial sequence)
<400> 1
atgtctggtt ctcatcacca tcaccatcac ggttctagcg gcgagaacct ctacttccaa 60
tccggcgcgc cattaatggt gagcaagggc gaggagctgt tcaccggggt ggtgcccatc 120
ctggtcgagc tggacggcga cgtaaacggc cacaagttca gcgtgtccgg cgagggcgag 180
ggcgatgcca cctacggcaa gctgaccctg aagttcatct gcaccaccgg caagctgccc 240
gtgccctggc ccaccctcgt gaccaccctg acctacggcg tgcagtgctt cagccgctac 300
cccgaccaca tgaagcagca cgacttcttc aagtccgcca tgcccgaagg ctacgtccag 360
gagcgcacca tcttcttcaa ggacgacggc aactacaaga cccgcgccga ggtgaagttc 420
gagggcgaca ccctggtgaa ccgcatcgag ctgaagggca tcgacttcaa ggaggacggc 480
aacatcctgg ggcacaagct ggagtacaac tacaacagcc acaacgtcta tatcatggcc 540
gacaagcaga agaatggcat caaggtgaac ttcaagatcc gccacaacat cgaggacggc 600
agcgtgcagc tcgccgacca ctaccagcag aacaccccca tcggcgacgg ccccgtgctg 660
ctgcccgaca accactacct gagcacccag tccgccctga gcaaagaccc caacgagaag 720
cgcgatcaca tggtcctgct ggagttcgtg accgccgccg ggatcactct cggcatggac 780
gagctgtaca agtccggaag atcttaactc gagggtcctg caacttgagg tagtcaagat 840
gcataataaa taacggattg tgtccgtaat cacacgtggt gcgtacgata acgcatagtg 900
tttttccctc cacttaaatc gaagggttgt gtcttggatc gcgcgggtca aatgtatatg 960
gttcatatac atccgcaggc acgtaataaa gcgaggggtt cgaatccccc cgttaccccc 1020
ggtaggggcc ca 1032
Claims (10)
1. A method of expressing an exogenous protein in a plant, the plant being lycium barbarum, the method comprising: introducing a recombinant tobacco mosaic virus expression vector containing a coding gene of an exogenous protein into agrobacterium to obtain recombinant agrobacterium; and infecting the medlar by using the recombinant agrobacterium to realize the expression of the foreign protein in the plant.
2. The method of claim 1, wherein: the recombinant tobacco mosaic virus expression vector is obtained by inserting the coding gene of the exogenous protein into a tobacco mosaic virus vector.
3. The method of claim 2, wherein: the tobacco mosaic virus vector is p 35S-30B.
4. A method according to any one of claims 1 to 3, wherein: the agrobacterium is agrobacterium strain GV 3101.
5. The method according to any one of claims 1 to 4, wherein: the fructus Lycii is a Lycium plant.
6. The method of claim 5, wherein: the Lycium plant is Lycium barbarum L, Lycium barbarum Mill, Lycium ruthenicum Murr, Lycium barbarum Pojark, Lycium truncatum Y.C.Wang, Lycium cylindracea Kuang, or Lycium yunnanense Kuang.
7. A kit of parts comprising the tobacco mosaic virus vector of any one of claims 2-4 and the Agrobacterium.
8. The kit of claim 7, wherein: the kit of parts further comprising lycium barbarum of any one of claims 1-6.
9. Use of a kit according to claim 7 or 8 for any one of the following applications:
x1, expressing a foreign protein in a plant;
x2, preparation of a product for expressing a foreign protein in a plant;
x3, production of a protein for medical use, vaccine or nutritional protein;
x4, preparation of products for the production of proteins for medical use, vaccines or nutritional proteins.
10. Use according to claim 9, characterized in that: the plant is medlar.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202011477593.2A CN114634948A (en) | 2020-12-15 | 2020-12-15 | Bioreactor for instantaneously expressing foreign protein by using medlar as tobacco mosaic virus |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202011477593.2A CN114634948A (en) | 2020-12-15 | 2020-12-15 | Bioreactor for instantaneously expressing foreign protein by using medlar as tobacco mosaic virus |
Publications (1)
Publication Number | Publication Date |
---|---|
CN114634948A true CN114634948A (en) | 2022-06-17 |
Family
ID=81945509
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202011477593.2A Pending CN114634948A (en) | 2020-12-15 | 2020-12-15 | Bioreactor for instantaneously expressing foreign protein by using medlar as tobacco mosaic virus |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN114634948A (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN115478076A (en) * | 2021-09-28 | 2022-12-16 | 昆明理工大学 | Method for improving instantaneous expression of exogenous protein of cultured tobacco cloud 87 and application |
-
2020
- 2020-12-15 CN CN202011477593.2A patent/CN114634948A/en active Pending
Non-Patent Citations (2)
Title |
---|
刘丹如;宋长征;张更林;杜国利;: "重组HIV-1壳体蛋白在转基因枸杞根系中的分泌表达", 中国生物工程杂志, vol. 27, no. 2, 25 February 2007 (2007-02-25), pages 53 - 57 * |
赵亚华, 何平, 高向阳: "根癌农杆菌介导的mMT-IcDNA转化枸杞及其表达的研究", 中国农业科学, vol. 33, no. 2, 31 December 2000 (2000-12-31) * |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN115478076A (en) * | 2021-09-28 | 2022-12-16 | 昆明理工大学 | Method for improving instantaneous expression of exogenous protein of cultured tobacco cloud 87 and application |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN110117320A (en) | Cotton GhCAL-D07 gene is promoting the application in flowering of plant | |
CN109735562A (en) | A kind of construction method of the effective root system transgenic system of economic plants | |
CN114634948A (en) | Bioreactor for instantaneously expressing foreign protein by using medlar as tobacco mosaic virus | |
CN106755080A (en) | It is a kind of quickly and efficiently in grape instantaneous conversion gene method for transformation | |
CN107827975A (en) | A kind of genetic recombination human serum albumins expressed with alfalfa and expression | |
CN103026966B (en) | Method for identifying tomato yellow leaf curl virus resistance by utilizing detached leaf | |
CN110117321A (en) | Cotton GhDctpp1-D11 gene is promoting the application in flowering of plant | |
CN110373417A (en) | Cotton GhMADS41-A04 gene is promoting the application in flowering of plant | |
CN105950644B (en) | The albumen and application of asparagus enzyme, namely chalcone isomerase gene and its coding | |
CN109266643A (en) | Necrosis virus infectious clone and its construction method in grape berry | |
Shadwick et al. | Propagation of plant viruses in hairy root cultures: a potential method for in vitro production of epitope vaccines and foreign proteins | |
CN107312077A (en) | Albumen and the application of wax plum CpSOC1 genes and its coding | |
CN107354140B (en) | The drought-resistant Protein G mNARK of plant and encoding gene and application | |
CN102533809A (en) | Jujube glutathione peroxidase gene | |
CN106636173B (en) | The method and its bacterial strain of enhanced green fluorescence protein label maize head dust-brand bacterial strain and application | |
CN105936914A (en) | Asparagus chalcone synthetase gene, encoded protein and applications thereof | |
CN102127566B (en) | Genetic transformation method for artemisia annua | |
CN101250532B (en) | Butterfly orchid PhAGCu gene coded sequence and uses thereof | |
CN111471689A (en) | Gene for improving resistance of soybean to cyst nematode disease and application thereof | |
CN108315334A (en) | The transcription factor of chlorophyll content of plant and its application of regulation and control plant petals Determination of Chlorophyll synthesis are improved under hot environment | |
CN108841856A (en) | The hairy root induction of suspension culture of Aquilaria sinensis and its genetic transforming method | |
CN108611353A (en) | A method of identifying Chinese rose floral genes function with virus induced gene silencing system | |
CN107904255A (en) | One identification method to grow tobacco to resistant to southern root knot nematode | |
CN110628785B (en) | Wild soybean salt-tolerant gene GmSULTR23.1 and application thereof | |
Israilovna et al. | GENE ENGINEERING IN PLANTS |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination |